Patient

Is an intervention safe and efficient?

For most neglected diseases, there is a lack of efficient drugs, vaccines and diagnostics. The reasons for this are a lack of economic interest, the complexity of many pathogens or a lack of clinical studies. Clinical studies are being conducted to evaluate new interventions, the off-label use of existing drugs is being investigated and specific diagnostic procedures are being developed.

 

Clicking on the departments and research groups will take you to the personal websites of our research groups. There you will find e.g. the contact of the respective group leader as well as their research projects and staff.

Section contact person

Prof. Dr Michael Ramharter

phone: +49 40 285380-511

email: ramharter@bnitm.de